Pre-Biopsy MRI Underused in U.S. Prostate Cancer Workups

Pre-biopsy MRI is 93% sensitive for prostate cancer vs 50% for systematic biopsy, yet only about one-third of U.S. workups use it. Barriers include urologist training, MRI access, and financial incentives favoring in-office biopsy.

• Major organizations including NCCN, AUA, and ASCO support pre-biopsy MRI, but adoption lags due to a urologist training gap and limited MRI access in rural areas.
• Disparities exist: Black patients, rural populations, and Medicaid-eligible individuals are less likely to receive pre-biopsy MRI.
• A Czech Republic implementation program achieved a 10-percentage-point increase in pre-biopsy MRI utilization.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.